IBREXAFUNGERP - AN OVERVIEW

quinupristin/dalfopristin will increase the amount or influence of avanafil by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep an eye on. CYP3A4 inhibitors may possibly minimize avanafil clearance escalating systemic publicity to avanafil; enhanced amounts might result in enhanced linked adverse activities; the most encourag